| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/25/2023 | Longboard Pharmaceuticals, Inc. | | Grant | Stock Option (Right to Buy) | 12.5k | $7.06 | $88.2k | | 05/25/2023 |
| 05/24/2022 | Longboard Pharmaceuticals, Inc. | | Grant | Stock Option (Right to Buy) | 12.4k | $4.40 | $54.4k | | 05/24/2022 |
| 01/03/2022 | Quince Therapeutics, Inc. | CRTX | Grant | Stock Option (right to buy) | 440k | $13.39 | $5.9M | | 01/03/2022 |
| 11/18/2021 | Quince Therapeutics, Inc. | CRTX | Exercise | Stock Option (Right to Buy) | 60k | $0.46 | $27.6k | | 11/18/2021 |
| 05/10/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 183 | $36.73 | $6.7k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 05/10/2021 |
| 05/10/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 6.3k | $35.81 | $226.1k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 05/10/2021 |
| 05/10/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 9.9k | $34.89 | $346k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 05/10/2021 |
| 05/10/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 13.6k | $33.75 | $458.5k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 05/10/2021 |
| 03/22/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 400 | $36.60 | $14.6k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 03/22/2021 |
| 03/22/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 300 | $36.58 | $11k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 03/22/2021 |
| 03/22/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 18.1k | $35.85 | $648.5k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 03/22/2021 |
| 03/22/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 11.2k | $35.10 | $393.5k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 03/22/2021 |
| 03/11/2021 | Longboard Pharmaceuticals, Inc. | | Grant | Stock Option (Right to Buy) | 12.4k | $16.00 | $197.9k | | 03/11/2021 |
| 03/11/2021 | Longboard Pharmaceuticals, Inc. | | Grant | Stock Option (Right to Buy) | 14.4k | $16.00 | $230.8k | | 03/11/2021 |
| 02/03/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 400 | $37.39 | $15k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/03/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 1.6k | $38.64 | $61.8k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/03/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 856 | $39.82 | $34.1k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/03/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 2k | $40.84 | $81.7k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/03/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 3.1k | $41.91 | $129.9k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/03/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 1.5k | $43.10 | $65.2k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/03/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 1.9k | $44.22 | $84k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/03/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 8k | $45.00 | $361.4k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/03/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 600 | $45.73 | $27.4k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/02/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 14.9k | $36.02 | $537.7k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/02/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 5.1k | $36.75 | $186.4k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/01/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 371 | $39.23 | $14.6k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/01/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 3.1k | $35.59 | $110.3k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/01/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 4.7k | $34.60 | $162.1k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/01/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 100 | $38.28 | $3.8k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/01/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 4.3k | $37.68 | $161.4k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 02/01/2021 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 7.5k | $36.56 | $272.7k | By the Zachary and Casey Lynch Living Trust dated February 24, 2009 | 02/01/2021 |
| 12/11/2020 | Quince Therapeutics, Inc. | CRTX | Grant | Stock Option (Right to Buy) | 175k | $29.60 | $5.2M | | 12/11/2020 |
| 02/06/2020 | Quince Therapeutics, Inc. | CRTX | Grant | Stock Option (Right to Buy) | 175k | $54.85 | $9.6M | | 02/06/2020 |